Global Health Limited reported FY2026 revenue growth of 19.6% YoY to ₹45,089 million, with PAT up 15.1% to ₹5,541 million.
The company added 623 beds (20.5% growth) including new hospitals in Noida (382 beds) and Ranchi (110 beds), while Noida incurred a ₹783 million EBITDA loss.
Medanta expanded its network with approved projects in Guwahati, Varanasi, and an 80-bed Indore cancer hospital acquisition, supported by a ₹45,000 million 5-year capex plan.
Operational metrics showed strong volume growth with IPD count up 16.0% and OPD count up 18.7% YoY, while ARPOB increased 6.1% to ₹66,550.